These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37766080)

  • 1. Effectiveness of Maternal Inactivated COVID-19 Vaccination against Omicron Infection in Infants during the First 12 Months of Life: A Test-Negative Case-Control Study.
    Zhong J; Wang W; Liu S; Chen Y; Xiong H; Meng X; Zhang D; Ma Y
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study.
    Jorgensen SCJ; Hernandez A; Fell DB; Austin PC; D'Souza R; Guttmann A; Brown KA; Buchan SA; Gubbay JB; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC;
    BMJ; 2023 Feb; 380():e074035. PubMed ID: 36754426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants.
    Goh O; Pang D; Tan J; Lye D; Chong CY; Ong B; Tan KB; Yung CF
    JAMA Netw Open; 2023 Nov; 6(11):e2342475. PubMed ID: 37948079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study.
    Zhang X; Wang Y; Hu C; Xu P; Ma L; Liu L; Sun J; Liu Y; Yang H; Pan F; Hu J; Cao C; Cheng K; Gao D; Lyu Y; Qin W
    Hum Vaccin Immunother; 2023 Dec; 19(1):2194189. PubMed ID: 36998173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effect of Inactivated COVID-19 Vaccines against Omicron BA.2 Infection in Guangzhou: A Test-Negative Case-Control Real-World Study.
    Zhang D; Zhong J; Xiong H; Li Y; Guo T; Peng B; Fang C; Kang Y; Tan J; Ma Y
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
    Simeone RM; Zambrano LD; Halasa NB; Fleming-Dutra KE; Newhams MM; Wu MJ; Orzel-Lockwood AO; Kamidani S; Pannaraj PS; Irby K; Maddux AB; Hobbs CV; Cameron MA; Boom JA; Sahni LC; Kong M; Nofziger RA; Schuster JE; Crandall H; Hume JR; Staat MA; Mack EH; Bradford TT; Heidemann SM; Levy ER; Gertz SJ; Bhumbra SS; Walker TC; Bline KE; Michelson KN; Zinter MS; Flori HR; Campbell AP; Randolph AG;
    MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(39):1057-1064. PubMed ID: 37874864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
    Halasa NB; Olson SM; Staat MA; Newhams MM; Price AM; Pannaraj PS; Boom JA; Sahni LC; Chiotos K; Cameron MA; Bline KE; Hobbs CV; Maddux AB; Coates BM; Michelson KN; Heidemann SM; Irby K; Nofziger RA; Mack EH; Smallcomb L; Schwartz SP; Walker TC; Gertz SJ; Schuster JE; Kamidani S; Tarquinio KM; Bhumbra SS; Maamari M; Hume JR; Crandall H; Levy ER; Zinter MS; Bradford TT; Flori HR; Cullimore ML; Kong M; Cvijanovich NZ; Gilboa SM; Polen KN; Campbell AP; Randolph AG; Patel MM;
    N Engl J Med; 2022 Jul; 387(2):109-119. PubMed ID: 35731908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.
    Xu S; Li J; Wang H; Wang F; Yin Z; Wang Z
    BMC Med; 2023 Apr; 21(1):160. PubMed ID: 37106390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.
    Huang Z; Xu S; Liu J; Wu L; Qiu J; Wang N; Ren J; Li Z; Guo X; Tao F; Chen J; Lu D; Sun X; Wang W
    BMC Med; 2022 Oct; 20(1):400. PubMed ID: 36266697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
    Tamandjou Tchuem CR; Auvigne V; Vaux S; Montagnat C; Paireau J; Monnier Besnard S; Gabet A; Benhajkassen N; Le Strat Y; Parent Du Chatelet I; Levy-Bruhl D
    Vaccine; 2023 Mar; 41(13):2280-2288. PubMed ID: 36870880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies.
    Song S; Madewell ZJ; Liu M; Longini IM; Yang Y
    Front Public Health; 2023; 11():1195908. PubMed ID: 37361171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
    JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life.
    Zerbo O; Ray GT; Fireman B; Layefsky E; Goddard K; Lewis E; Ross P; Omer S; Greenberg M; Klein NP
    Nat Commun; 2023 Feb; 14(1):894. PubMed ID: 36854660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans.
    Young-Xu Y; Zwain GM; Izurieta HS; Korves C; Powell EI; Smith J; Balajee A; Holodniy M; Beenhouwer DO; Rodriguez-Barradas MC; Brown ST; Marconi VC
    BMJ Open; 2022 Aug; 12(8):e063935. PubMed ID: 35922100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.